The NMDA receptor as a target for cognitive enhancement
- 1 January 2013
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 64, 13-26
Abstract
No abstract availableKeywords
Funding Information
- MRC (G0601509, G061812)
- BBSRC (BB/F012519/1 and BB/J015938/1)
- NIH (MH60252)
This publication has 203 references indexed in Scilit:
- Metabotropic glutamate receptors as therapeutic targets for schizophreniaNeuropharmacology, 2012
- Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinasesThe EMBO Journal, 2011
- Selective Remediation of Reversal Learning Deficits in the Neurodevelopmental MAM Model of Schizophrenia by a Novel mGlu5 Positive Allosteric ModulatorNeuropsychopharmacology, 2011
- The likelihood of cognitive enhancementPharmacology Biochemistry and Behavior, 2011
- Facilitation of Long-Term Potentiation by Muscarinic M1 Receptors Is Mediated by Inhibition of SK ChannelsNeuron, 2010
- A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsNature Communications, 2010
- Casein Kinase 2 Regulates the NR2 Subunit Composition of Synaptic NMDA ReceptorsNeuron, 2010
- Long-term potentiation depends on release of d-serine from astrocytesNature, 2010
- Dual Palmitoylation of NR2 Subunits Regulates NMDA Receptor TraffickingNeuron, 2009
- mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial LearningNeuropsychopharmacology, 2009